Drugs / C-type natriuretic peptide
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01075776 | Jan 2020 → Jan 2022 | ischemic disease | Queen Mary University of London | Withdrawn | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | C-type natriuretic peptide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01075776 ↗ |
| Known as | CNP | “C-type natriuretic peptide (CNP)” NCT01075776 ↗ |
| Modality | Peptide | “C-type natriuretic peptide (CNP)” NCT01075776 ↗ |
| Route | Other | “360 pmol/min for 15 minutes intra-arterially” NCT01075776 ↗ |